CN103961438B - A kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease - Google Patents

A kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease Download PDF

Info

Publication number
CN103961438B
CN103961438B CN201410238791.1A CN201410238791A CN103961438B CN 103961438 B CN103961438 B CN 103961438B CN 201410238791 A CN201410238791 A CN 201410238791A CN 103961438 B CN103961438 B CN 103961438B
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
fici pumilae
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410238791.1A
Other languages
Chinese (zh)
Other versions
CN103961438A (en
Inventor
刘洪华
杨瑞东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410238791.1A priority Critical patent/CN103961438B/en
Publication of CN103961438A publication Critical patent/CN103961438A/en
Application granted granted Critical
Publication of CN103961438B publication Critical patent/CN103961438B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Treat a Chinese medicine for qi stagnation and blood stasis type pelvic inflammatory disease, this Chinese medicine is made up of Folium Acronychiae, Caulis fici pumilae (Fructus Fici Pumilae), Fructus Choerospondiatis, Semen Bauhiniae championii, Radix limonii sinensis, Rhizoma Corydalis, Herba Lycopi, Radix Seu Caulis Mucunae Sempervirentis, Radix Arnebiae (Radix Lithospermi), Rhizoma et Radix Dysosmae Veitchii.Clinical can be used for, treats qi stagnation and blood stasis type pelvic inflammatory disease.

Description

A kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease
Technical field
The invention belongs to technical field of Chinese medicines, especially relate to a kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease.
Background technology
Pelvic inflammatory disease refers to that female internal genital organs and connective tissue basin peritoneum around thereof are inflamed.Primary disease is mainly in Status of Married Child-bearing aged Women, in recent years due to the various factors such as to increase of the change of consciousness and family planning operation, makes pelvic inflammatory disease sickness rate in rising trend, has become common gynecological disease, frequently-occurring disease.Due to long period inflammatory stimulus, local patholoic change is fibrous connective tissue hypertrophy, whenever menstrual period or other reason cause pelvic congestion, thus there is stomachache, dysmenorrhea, menoxenia, the very then symptom such as infertility, general anti-inflammatory treatment curative effect is not good enough, and the state of an illness is often delayed difficult.Motherland's traditional medicine treats this disease certain advantage, and the long-term practice through inventor draws, Chinese medicine is controlled qi stagnation and blood stasis type pelvic inflammatory disease and had better effect, and obtains good effect.
Summary of the invention
The object of the present invention is to provide that a kind of therapeutic effect is good, effective percentage is high, Chinese medicine to the treatment qi stagnation and blood stasis type pelvic inflammatory disease of human non-toxic's side effect.
The object of the present invention is achieved like this, according to Chinese medical theory, utilizing the property of medicine of Chinese medicine uniqueness, adopting Folium Acronychiae, Caulis fici pumilae (Fructus Fici Pumilae), Fructus Choerospondiatis, Semen Bauhiniae championii, Radix limonii sinensis, Rhizoma Corydalis, Herba Lycopi, Radix Seu Caulis Mucunae Sempervirentis, Radix Arnebiae (Radix Lithospermi), Rhizoma et Radix Dysosmae Veitchii according to certain compatibility requirement, through being processed into.
Prepare Chinese medicine of the present invention to be made up of following raw material medicaments: Folium Acronychiae 20-40 part, Caulis fici pumilae (Fructus Fici Pumilae) 20-30 part, Fructus Choerospondiatis 20-30 part, Semen Bauhiniae championii 15-25 part, Radix limonii sinensis 15-25 part, Rhizoma Corydalis 15-25 part, Herba Lycopi 10-20 part, Radix Seu Caulis Mucunae Sempervirentis 10-20 part, Radix Arnebiae (Radix Lithospermi) 10-15 part, Rhizoma et Radix Dysosmae Veitchii 0.5-1 part.
Optimum weight part of raw material of Chinese medicine medicine of the present invention is: Folium Acronychiae 30 parts, Caulis fici pumilae (Fructus Fici Pumilae) 25 parts, Fructus Choerospondiatis 25 parts, Semen Bauhiniae championii 20 parts, Radix limonii sinensis 20 parts, Rhizoma Corydalis 20 parts, Herba Lycopi 15 parts, Radix Seu Caulis Mucunae Sempervirentis 15 parts, Radix Arnebiae (Radix Lithospermi) 12 parts, Rhizoma et Radix Dysosmae Veitchii 0.7 part.
The weight portion of raw material of Chinese medicine medicine of the present invention is: Folium Acronychiae 20 parts, Caulis fici pumilae (Fructus Fici Pumilae) 20 parts, Fructus Choerospondiatis 20 parts, Semen Bauhiniae championii 15 parts, Radix limonii sinensis 15 parts, Rhizoma Corydalis 15 parts, Herba Lycopi 10 parts, Radix Seu Caulis Mucunae Sempervirentis 10 parts, Radix Arnebiae (Radix Lithospermi) 10 parts, Rhizoma et Radix Dysosmae Veitchii 0.5 part.
The weight portion of raw material of Chinese medicine medicine of the present invention is: Folium Acronychiae 40 parts, Caulis fici pumilae (Fructus Fici Pumilae) 30 parts, Fructus Choerospondiatis 30 parts, Semen Bauhiniae championii 25 parts, Radix limonii sinensis 25 parts, Rhizoma Corydalis 25 parts, Herba Lycopi 20 parts, Radix Seu Caulis Mucunae Sempervirentis 20 parts, Radix Arnebiae (Radix Lithospermi) 15 parts, Rhizoma et Radix Dysosmae Veitchii 1 part.
The pharmacological action of Chinese medicine of the present invention is as follows:
Folium Acronychiae: pungent, bitter, flat.Return lung, Liver Channel.Dispelling wind stopping cough, regulating QI to relieve pain, promoting blood circulation and detumescence.Clinical in bronchitis, cold cough, rheumatic lumbago and scelalgia, stomachache, colicky, traumatic injury, the diseases such as furuncle swelling toxin.
Caulis fici pumilae (Fructus Fici Pumilae): sour, cool.Expelling wind and removing dampness, promoting blood circulation to remove obstruction in the collateral, removing toxic substances and promoting subsidence of swelling.Clinical in rheumatic arthralgia, sciatica, dysentery, urine drenches, edema, malaria, amenorrhea, and postnatal blood stasis is suffered from abdominal pain, laryngopharynx swelling and pain, orchitis, dermatitis rhus, pain pyogenic infections from tumour or sore, the diseases such as traumatic injury.
Fructus Choerospondiatis: sweet, sour, flat.Return spleen, Liver Channel.Promoting flow of QI and blood, nourishing blood to tranquillize the mind, removing food stagnancy, removing toxic substances.For qi depression to blood stasis, chest pain, shortness of breath and palpitation, neurasthenia, insomnia, bronchitis, dyspepsia abdominal distention, diarrhoea, hernia, burn and scald etc.
Semen Bauhiniae championii: bitter, Xin Wen.Return liver, stomach warp.For the seed of leguminous plant Caulis Bauhihiae Championii.Promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling.For stagnation of QI and blood, distending pain over the hypochondrium, gastric abscess, traumatic injury.
Radix limonii sinensis: bitter, acrid, cold.Return lung, liver, large intestine channel.Blood circulation promoting and blood stasis dispelling, clearing and antitussive.Clinical in blood stasis mass in the abdomen in abdomen, the diseases such as epersalgia cough.
Rhizoma Corydalis: acrid, bitter, warm.Return liver, stomach, the heart, lung, spleen channel.Invigorate blood circulation, dissipating blood stasis, regulate the flow of vital energy, pain relieving.For all pains of trusted subordinate's waist knee joint, menoxenia, traumatic injury etc.
Herba Lycopi: bitter, pungent, tepor.Return liver, spleen channel.Blood circulation promoting and blood stasis dispelling, promoting the circulation of QI for relieving swelling, removing toxicity for eliminating carbuncles.Cure mainly women's amenorrhea, dysmenorrhea, the stasis of blood in puerperal stagnant stomachache , mass in the abdomen edema, traumatic injury, carbuncle sore tumefacting virus etc.
Radix Seu Caulis Mucunae Sempervirentis: bitter, warm.Return liver, stomach warp.Promoting blood flow to regulate menstruation, relaxing muscles and tendons of enriching blood.For having through uncomfortable, dysmenorrhea, amenorrhea, puerperal blood deficiency, anemia, rheumatic arthralgia, numb limbs and tense tendons, traumatic injury etc.
Radix Arnebiae (Radix Lithospermi): bitter, cold.GUIXIN, Liver Channel.Removing heat from blood, invigorate blood circulation, rash, removing toxic substances.Cure mainly macule, measles, spit blood, epistaxis, hematuria, purpura, jaundice, carbuncle, scald.
Rhizoma et Radix Dysosmae Veitchii: acrid, bitter, warm.Preventing phlegm from forming and stopping coughing, loose wind dehumidifying, blood-activating analgetic.Clinical in cough with copious phlegm, rheumatic arthralgia, gout, the diseases such as traumatic injury.
Qi stagnation and blood stasis type pelvic inflammatory disease belongs to Chinese medicine " leukorrheal diseases ", " infertile ", " dysmenorrhea ", " menoxenia ", “ mass in the abdomen ", the category such as " metrorrhagia ".The traditional Chinese medical science think primary disease due to through row, puerperal vessels of the uterus hollow, or usually have a delicate constitution, blood room is just opened, and evil poison invades uterus, vessels of the uterus, collaterals of the uterus in taking advantage of a weak point in opponent's defence, and turbid damp evil poison damage punching is appointed and superintended and directed band, fights and ties, cause stagnation of QI-blood and fall ill with QI and blood.Folium Acronychiae regulating QI to relieve pain in the present invention, promoting blood circulation and detumescence is monarch drug, promoting blood circulation to remove obstruction in the collateral, removing toxic substances and promoting subsidence of swelling, Fructus Choerospondiatis promoting flow of QI and blood, removing toxic substances, for ministerial drug, Semen Bauhiniae championii promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling, Radix limonii sinensis blood circulation promoting and blood stasis dispelling, Rhizoma Corydalis is invigorated blood circulation, dissipating blood stasis, regulate the flow of vital energy, Herba Lycopi's blood circulation promoting and blood stasis dispelling, circulation of qi promoting message, removing toxicity for eliminating carbuncles, Radix Seu Caulis Mucunae Sempervirentis promoting blood flow to regulate menstruation, Radix Arnebiae (Radix Lithospermi) removing heat from blood, invigorates blood circulation, detoxifies, Rhizoma et Radix Dysosmae Veitchii eliminating phlegm and removing dampness, blood-activating analgetic.All medicines share, and regulating QI to relieve pain is played, effect of blood circulation promoting and blood stasis dispelling, removing toxicity for eliminating carbuncles altogether by full side, reach effect for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease.
Chinese medicine composition of the present invention was in 2010 to 2012 the routine patients of clinical observation qi stagnation and blood stasis type pelvic inflammatory disease 41, and clinical report is as follows:
1, physical data
In 41 routine patients, in age 21-55 year, the course of disease is many at 3 months to 3 years not etc., 33 years old mean age.
2, diagnostic criteria
" Chinese medical disease Standardization of diagnosis and curative effect " that diagnosis basis State Administration of Traditional Chinese Medicine issues:
(1) lower abdomen and lumbago, lower abdomen falling inflation, lumbosacral region are ached, after fatigue of being everlasting, sexual intercourse, defecation time, increase the weight of before and after menstruation, can increase or leucorrhoea grow in quantity with low grade fever, menstruation;
(2) gynecologial examination: abdominal part has slight tenderness, can touch streak thing in side, uterus or bilateral during fallopian tube inflammation, and have tenderness, and during the inflammation of pelvic cavity connective tissue, side, uterus or bilateral have lamellar to thicken and tenderness;
(3) all cases all makes a definite diagnosis prompting through ultrasonic, and uterus heavy wall and pelvic cavity have hydrops, or has fallopian tube increase thick or have cystic enclosed mass etc.
Qi stagnation and blood stasis type pelvic inflammatory disease clinical symptoms: lower abdominal distention pain, more so premenstrual, irregular menstrual period, sometimes increase through amount, color secretly has block, few time many during leukorrhagia, and tongue is dark or have trace speckle, stringy pulse or string puckery.
3, Therapeutic Method
3.1 prescriptions: Folium Acronychiae 30g, Caulis fici pumilae (Fructus Fici Pumilae) 25g, Fructus Choerospondiatis 25g, Semen Bauhiniae championii 20g, Radix limonii sinensis 20g, Rhizoma Corydalis 20g, Herba Lycopi 15g, Radix Seu Caulis Mucunae Sempervirentis 15g, Radix Arnebiae (Radix Lithospermi) 12g, Rhizoma et Radix Dysosmae Veitchii 0.7g.
3.2 methods of preparation and use: said medicine routinely technique makes decoction, every day 1 dose, every day 2 times 7 days was 1 course for the treatment of.
4, therapeutic outcome:
4.1 formulate with reference to " Chinese medical disease Standardization of diagnosis and curative effect ":
Cure: clinical symptoms, sign disappear, gynecological and ultrasonic examination report show no obvious abnormalities;
Effective: clinical symptoms, sign disappear, and gynecological and ultrasonic examination are significantly improved;
Effective: clinical symptoms, sign and gynecological and ultrasonic all have alleviate;
Invalid: clinical symptoms, sign and gynecological and ultrasonic examination are all without improvement.
4.2 results: in 41 routine patients, cure 16 examples (39%), effective 15 examples (36.6%), effective 7 examples (17.1%), and invalid 3 examples (7.3%), total effective rate is 92.7%.
5, model case
5.1 fourths, female, 31 years old, because contraceptive failure is in local hospital pedestrian stream art before 2 years, postoperative fever, aversion to cold, abdominal pain with tenderness, was diagnosed as acute pelvic inflammatory disease, anti-infective therapy's first quarter moon and healing.After this hidden swollen pain catch cropping of lower abdomen, menstrual period increase the weight of, irregular menses, more or less mensis in amount, the dim fixture block of color, premenstrual distending pain of the breast, and dry during stool, tongue is dark, stringy pulse.Gynaecological examination: retroposition of uterus, limitation of activity, ride side attachment increases thick.Be diagnosed as qi stagnation and blood stasis type pelvic inflammatory disease.Take medicine of the present invention, treat 1 course for the treatment of, symptom obviously alleviates, and lower abdomen Tong bitterly and lumbosacral region is miserable is clearly better, and continue to take 2 courses for the treatment of, all diseases disappear.Follow up a case by regular visits to after half a year and have no recurrence.
5.2 Wang, 33 years old, lower abdomen dull pain usually, liked warm pain relieved by pressing, coldness of the body and aversion to cold, delayed menstrual cycle, and amount is few, the dark fixture block of color, and leukorrhagia is on the high side, and color white matter is rare, gas raw meat, and tongue is dark, and tongue is white, and deep pulse is string slightly.Left side attachment thickens tenderness, and ultrasonic examination is pointed out: pelvic hydrops is a small amount of, is diagnosed as qi stagnation and blood stasis type pelvic inflammatory disease.Take medicine of the present invention, every day 1 dose, after 1 course for the treatment of, symptom is clearly better, and continues to take 3 courses for the treatment of, and recovery from illness, follows up a case by regular visits to after half a year and have no recurrence.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated, and this embodiment following does not only limit the present invention for illustration of the present invention.
Embodiment 1, a kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease is made up of Folium Acronychiae 20g, Caulis fici pumilae (Fructus Fici Pumilae) 20g, Fructus Choerospondiatis 20g, Semen Bauhiniae championii 15g, Radix limonii sinensis 15g, Rhizoma Corydalis 15g, Herba Lycopi 10g, Radix Seu Caulis Mucunae Sempervirentis 10g, Radix Arnebiae (Radix Lithospermi) 10g, Rhizoma et Radix Dysosmae Veitchii 0.5g.
Embodiment 2, a kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease is made up of Folium Acronychiae 30g, Caulis fici pumilae (Fructus Fici Pumilae) 25g, Fructus Choerospondiatis 25g, Semen Bauhiniae championii 20g, Radix limonii sinensis 20g, Rhizoma Corydalis 20g, Herba Lycopi 15g, Radix Seu Caulis Mucunae Sempervirentis 15g, Radix Arnebiae (Radix Lithospermi) 12g, Rhizoma et Radix Dysosmae Veitchii 0.7g.
Embodiment 3, a kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease is made up of Folium Acronychiae 40g, Caulis fici pumilae (Fructus Fici Pumilae) 30g, Fructus Choerospondiatis 30g, Semen Bauhiniae championii 25g, Radix limonii sinensis 25g, Rhizoma Corydalis 25g, Herba Lycopi 20g, Radix Seu Caulis Mucunae Sempervirentis 20g, Radix Arnebiae (Radix Lithospermi) 15g, Rhizoma et Radix Dysosmae Veitchii 1g.

Claims (4)

1. treat a Chinese medicine for qi stagnation and blood stasis type pelvic inflammatory disease, it is characterized in that it is made up of following raw material medicaments:
Folium Acronychiae 20-40 part, Caulis fici pumilae (Fructus Fici Pumilae) 20-30 part, Fructus Choerospondiatis 20-30 part, Semen Bauhiniae championii 15-25 part, Radix limonii sinensis 15-25 part, Rhizoma Corydalis 15-25 part, Herba Lycopi 10-20 part, Radix Seu Caulis Mucunae Sempervirentis 10-20 part, Radix Arnebiae (Radix Lithospermi) 10-15 part, Rhizoma et Radix Dysosmae Veitchii 0.5-1 part.
2. Chinese medicine according to claim 1, is characterized in that it is made up of following raw material medicaments:
Folium Acronychiae 30 parts, Caulis fici pumilae (Fructus Fici Pumilae) 25 parts, Fructus Choerospondiatis 25 parts, Semen Bauhiniae championii 20 parts, Radix limonii sinensis 20 parts, Rhizoma Corydalis 20 parts, Herba Lycopi 15 parts, Radix Seu Caulis Mucunae Sempervirentis 15 parts, Radix Arnebiae (Radix Lithospermi) 12 parts, Rhizoma et Radix Dysosmae Veitchii 0.7 part.
3. Chinese medicine according to claim 1, is characterized in that being made up of following raw material medicaments:
Folium Acronychiae 20 parts, Caulis fici pumilae (Fructus Fici Pumilae) 20 parts, Fructus Choerospondiatis 20 parts, Semen Bauhiniae championii 15 parts, Radix limonii sinensis 15 parts, Rhizoma Corydalis 15 parts, Herba Lycopi 10 parts, Radix Seu Caulis Mucunae Sempervirentis 10 parts, Radix Arnebiae (Radix Lithospermi) 10 parts, Rhizoma et Radix Dysosmae Veitchii 0.5 part.
4. Chinese medicine according to claim 1, is characterized in that being made up of following raw material medicaments:
Folium Acronychiae 40 parts, Caulis fici pumilae (Fructus Fici Pumilae) 30 parts, Fructus Choerospondiatis 30 parts, Semen Bauhiniae championii 25 parts, Radix limonii sinensis 25 parts, Rhizoma Corydalis 25 parts, Herba Lycopi 20 parts, Radix Seu Caulis Mucunae Sempervirentis 20 parts, Radix Arnebiae (Radix Lithospermi) 15 parts, Rhizoma et Radix Dysosmae Veitchii 1 part.
CN201410238791.1A 2014-06-03 2014-06-03 A kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease Expired - Fee Related CN103961438B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410238791.1A CN103961438B (en) 2014-06-03 2014-06-03 A kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410238791.1A CN103961438B (en) 2014-06-03 2014-06-03 A kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease

Publications (2)

Publication Number Publication Date
CN103961438A CN103961438A (en) 2014-08-06
CN103961438B true CN103961438B (en) 2015-11-04

Family

ID=51231759

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410238791.1A Expired - Fee Related CN103961438B (en) 2014-06-03 2014-06-03 A kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease

Country Status (1)

Country Link
CN (1) CN103961438B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105267506A (en) * 2015-12-07 2016-01-27 潘剑崎 Medicine for treating pelvic inflammatory disease
CN105327193A (en) * 2015-12-09 2016-02-17 田元华 Traditional Chinese medicine for treating qi and yin deficiency pelvic inflammation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101757379A (en) * 2008-11-20 2010-06-30 赵欣 Traditional Chinese medicine formula for treating female pelvic inflammation
CN103393821A (en) * 2013-08-05 2013-11-20 杨心洁 Traditional Chinese medicine composition for treating chronic pelvic inflammation and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003239919A1 (en) * 2002-06-03 2003-12-19 Activbiotics, Inc. Intravenous rifalazil formulation and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101757379A (en) * 2008-11-20 2010-06-30 赵欣 Traditional Chinese medicine formula for treating female pelvic inflammation
CN103393821A (en) * 2013-08-05 2013-11-20 杨心洁 Traditional Chinese medicine composition for treating chronic pelvic inflammation and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
自拟妇科消炎方治疗慢性盆腔炎55例;崔翠林;《光明中医》;20090831;第24卷(第8期);第1472-1473页 *

Also Published As

Publication number Publication date
CN103961438A (en) 2014-08-06

Similar Documents

Publication Publication Date Title
CN105477564A (en) Traditional Chinese medicine composition for treating prosopalgia
CN103961438B (en) A kind of Chinese medicine for the treatment of qi stagnation and blood stasis type pelvic inflammatory disease
CN103610915B (en) Traditional Chinese medicine for treating swelling and pain in throat
CN105616754A (en) Pill medicine for treating wind-heat attacking upward syndrome and preparation method thereof
CN104971253A (en) Traditional Chinese medicine composition preparation for treating allergic rhinitis
CN103655820A (en) Traditional Chinese medicine formula for treating cold
CN103610772B (en) The Chinese medicine for the treatment of cerebral thrombosis
CN105395890A (en) Traditional Chinese medicine preparation used for treating extensor carpi tenosynovitis
CN104740036A (en) Traditional Chinese medicine composition for treating Qi stagnation and blood stasis amenorrhea
CN104189477A (en) Traditional Chinese medicine formula for treating barbiers
CN103845547A (en) Traditional Chinese medicine decoction for treating mumps
CN103977258A (en) Traditional Chinese medicament for treating abdominal lump type pelvic inflammation
CN103961451B (en) A kind of Chinese medicine for the treatment of cold and stagnate type pelvic inflammatory disease
CN104523975A (en) Tincture for treating scapulohumeral periarthritis and preparation method of tincture
CN105012513A (en) Traditional Chinese medicine decoction for treating urinary system infection
CN104998106A (en) Traditional Chinese medicine composition for treating allergic rhinitis
CN104491537A (en) Traditional Chinese medicine composition for treating rheumatic heart disease
CN104491255A (en) Traditional Chinese medicine preparation for treating acute cholecystitis
CN104623208A (en) Traditional Chinese medicine composition for treating pathogenic toxin internal exuberance type rubella
CN104352953B (en) A kind of Chinese medicine composition for the treatment of chronic adnexitis
CN104435590A (en) Traditional Chinese medicine prescription for treating chronic pelvic inflammation and preparation method thereof
CN104288675A (en) Traditional Chinese medicine formula for preventing and treating hepatitis A and preparation method thereof
CN103494992B (en) A kind of Chinese medicine composition for the treatment of costal chondritis
CN103566308A (en) Traditional Chinese medicine for treating primary dysmenorrhea
CN103721225B (en) A kind of medicine for the treatment of piriformis syndrome and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151104

Termination date: 20160603